Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
Emma Smith, Markella V. Zanni, Heather J. Ribaudo, Carl J. Fichtenbaum et al.
Citations
3 citations
Journal
Open Forum Infectious Diseases
Topics
HIV-related health complications and treatments
Field-Weighted Citation Impact (FWCI)
6.76
article
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
Emma Smith, Markella V. Zanni, Heather J. Ribaudo, Carl J. Fichtenbaum, Sarah M Chu, Indira Brar, Cristina Gómez‐Ayerbe, Javier Valencia, Roger Bedimo, Pamela S. Douglas, Steven Grinspoon, Michael T. Lu, Carlos Malvestutto, Gerald S. Bloomfield, Marissa R Diggs, Judith S. Currier, Kathleen V. Fitch, Judith A. Aberg, Maya Watanabe, José Valdez Madruga
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Open Forum Infectious DiseasesVol. 12(4)
Institutions
Harvard University (US), University of California, Los Angeles (US), Duke University (US), Asociación Civil Impacta Salud y Educación (PE), The Ohio State University Wexner Medical Center (US), Henry Ford Hospital (US), University of California System (US), Massachusetts General Hospital (US), Clinical Research Institute (US), Southwestern Medical Center (US), Cancer Research And Biostatistics (US), Duke Institute for Health Innovation (US), Hospital Clínico Universitario Virgen de la Victoria (ES), Instituto de Investigación Biomédica de Málaga (ES), The Ohio State University (US), The University of Texas Southwestern Medical Center (US), University of Cincinnati Medical Center (US), Icahn School of Medicine at Mount Sinai (US)